Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)
CNY 30.05
(0.0%)
CNY 30.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -174.59 Million | -119.67 Million | -17.76 Million | 15.59 Million | 33.98 Million | 10.94 Million |
| Net Income | -374.9 Million | -140.56 Million | -34.16 Million | 16.52 Million | 12.58 Million | 16.73 Million |
| Depreciation & Amortization | 72.14 Million | 58.59 Million | 51.98 Million | 37.31 Million | 34.57 Million | 22.61 Million |
| Deferred income taxes | 69.88 Million | -29.4 Million | -19.54 Million | -7.06 Million | -7.51 Million | -6.07 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 19.85 Million | 20.4 Million | -21.93 Million | -35.71 Million | -14.32 Million | -33.46 Million |
| Other non-cash items | 108.3 Million | -58.11 Million | -13.64 Million | -2.52 Million | 1.15 Million | 5.05 Million |
| Investing Cash Flow | -207.4 Million | -197.2 Million | -174.38 Million | -35 Million | -73.47 Million | -319.39 Million |
| Investments in PPE | -201.23 Million | -195.96 Million | -174.4 Million | -54.45 Million | -67.81 Million | -229.26 Million |
| Acquisitions | 33.16 Thousand | 35.02 Million | 22.22 Thousand | 26.54 Million | 10.49 Million | -89.81 Million |
| Investment purchases | -9.54 Million | -1.56 Million | - | -17.6 Million | -24.2 Million | -350 Thousand |
| Sales/Maturities of investments | 89.85 Thousand | 298.82 Thousand | - | -26.54 Million | 41.9 Thousand | 229.29 Million |
| Other Investing Activities | 3.25 Million | -34.99 Million | 0.06 | 37.04 Million | 8 Million | -229.26 Million |
| Financing Cash Flow | 349.71 Million | 162.53 Million | 445.57 Million | 61.68 Million | 47.3 Million | -13.7 Million |
| Debt repayment | -147.52 Million | -248.35 Million | -192.79 Million | -129 Million | -105.6 Million | -38 Million |
| Dividends payments | -17.39 Million | -10.35 Million | -9.17 Million | -8.83 Million | -7.37 Million | -15.23 Million |
| Common Stock Repurchased | - | - | - | - | -33.72 Million | -18.46 Million |
| Common Stock Issuance | - | - | - | - | 33.72 Million | - |
| Other Financing Activities | 220.45 Million | 421.23 Million | 647.54 Million | 199.51 Million | 160.27 Million | 39.53 Million |
| Accounts receivables | -75.44 Million | -10.97 Million | -8.18 Million | 1.87 Million | 11.89 Million | -12.72 Million |
| Accounts payables | 146.94 Million | 51.5 Million | 36.62 Million | -10.15 Million | -20.54 Million | -13.84 Million |
| Inventory | -49.3 Million | 9.28 Million | -30.83 Million | -20.37 Million | 1.84 Million | -820.06 Thousand |
| Other working capital | -2.33 Million | -29.4 Million | -19.54 Million | -7.06 Million | -7.51 Million | -32.64 Million |
| Cash at beginning of period | 234.8 Million | 389.16 Million | 135.73 Million | 93.47 Million | 85.65 Million | 407.81 Million |
| Cash at end of period | 202.51 Million | 234.8 Million | 389.16 Million | 135.73 Million | 93.47 Million | 85.65 Million |
| Capital Expenditure | -201.23 Million | -195.96 Million | -174.4 Million | -54.45 Million | -67.81 Million | -229.26 Million |
| Effect of forex changes on cash | 3160.47 | -11.5 Thousand | - | - | 0.79 | - |
| Net cash flow / Change in cash | -32.28 Million | -154.36 Million | 253.42 Million | 42.26 Million | 7.81 Million | -322.15 Million |
| Free Cash Flow | -375.83 Million | -315.64 Million | -192.17 Million | -38.85 Million | -33.82 Million | -218.31 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -34.6 Million | -21.39 Million | -14.64 Million | -374.9 Million | -152.76 Million | -38.61 Million |
| Depreciation & Amortization | - | 25.33 Million | 25.33 Million | 72.14 Million | 72.14 Million | -33.01 Million |
| Deferred income taxes | - | - | - | 69.88 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -5.62 Million | - | 19.85 Million | -127.08 Million | 60.37 Million |
| Other non-cash items | 39.63 Million | 55.12 Million | 1.42 Million | 108.3 Million | 196.12 Million | 2.61 Million |
| Investing Cash Flow | -11.96 Million | -9.98 Million | -8.3 Million | -207.4 Million | 7.58 Million | -56.36 Million |
| Investments in PPE | -11.96 Million | -9.98 Million | -24.88 Million | -201.23 Million | 5.62 Million | -48.2 Million |
| Acquisitions | - | 150.00 | -16.58 Million | 33.16 Thousand | 1.28 Million | 8661.75 |
| Investment purchases | - | - | -1.05 Million | -9.54 Million | -1.37 Million | -8.17 Million |
| Sales/Maturities of investments | - | - | 17.64 Million | 89.85 Thousand | 89.85 Thousand | 8.16 Million |
| Other Investing Activities | - | 8.29 Million | 16.58 Million | 3.25 Million | 1.96 Million | -8.16 Million |
| Financing Cash Flow | 3.18 Million | -53.43 Million | 22.21 Million | 349.71 Million | -1.81 Million | -12.29 Million |
| Debt repayment | -7.41 Million | -48.99 Million | -26.85 Million | -147.52 Million | -1.78 Million | -64.35 Million |
| Dividends payments | - | -4.43 Million | -4.63 Million | -17.39 Million | -4.52 Million | -5.27 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.23 Million | -4.43 Million | -4.63 Million | 220.45 Million | 1.8 Million | 57.33 Million |
| Accounts receivables | - | -12.71 Million | - | -75.44 Million | -75.44 Million | 16.28 Million |
| Accounts payables | - | - | - | 146.94 Million | - | - |
| Inventory | - | 407 Thousand | - | -49.3 Million | -49.3 Million | 38.02 Million |
| Other working capital | - | 6.68 Million | - | -2.33 Million | -2.33 Million | 6.07 Million |
| Cash at beginning of period | 131.08 Million | 203.21 Million | 208.75 Million | 234.8 Million | 208.32 Million | 285.61 Million |
| Cash at end of period | 127.34 Million | 130.53 Million | 203.46 Million | 202.51 Million | 202.51 Million | 208.32 Million |
| Capital Expenditure | -11.96 Million | -9.98 Million | -24.88 Million | -201.23 Million | 5.62 Million | -48.2 Million |
| Effect of forex changes on cash | - | - | -2.00 | 3160.47 | 3160.00 | -0.31 |
| Net cash flow / Change in cash | -3.74 Million | -72.67 Million | -5.29 Million | -32.28 Million | -5.8 Million | -77.28 Million |
| Free Cash Flow | -6.93 Million | -1.59 Million | -38.1 Million | -375.83 Million | -5.96 Million | -56.83 Million |
1309
KARNEL-B
SSBI
ENOG
XELTB
9332